Vyant Bio, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.194

+0 (+0%)

At Close: Mar 28, 2024

Currently predicting for Mon, 6 May 2024

VYNT Predictions History

BE THE FIRST TO PREDICT

The excellent way of becoming a better trader

Easy to use
Enhance your skills
Predict as many as you like
Request predictions
Gather points

Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

About Vyant Bio, Inc.

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency diso... VYNT Profile

Golden Star

Ticker	Date	Change	Price
BSCQ	Apr 30	0.393%	$19.09
EQC	Apr 30	1.76%	$18.72
HRB	Apr 30	1.69%	$47.23
REG	Apr 30	1.35%	$59.22
INGR	Apr 30	0.576%	$114.59
BSJP	Apr 29	0.175%	$22.91
LYG	Apr 29	0.781%	$2.56
ORA	Apr 29	3.46%	$64.48
DHT	Apr 24	4.34%	$11.28
LPLA	Apr 19	2.62%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In